Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi, Laura Senovilla, Laurence Zitvogel, et al.
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 3, pp. 215-233
Closed Access | Times Cited: 647

Showing 1-25 of 647 citing articles:

Immunogenic Cell Death in Cancer Therapy
Guido Kroemer, Lorenzo Galluzzi, Oliver Kepp, et al.
Annual Review of Immunology (2012) Vol. 31, Iss. 1, pp. 51-72
Closed Access | Times Cited: 2840
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek, et al.
Nature reviews. Cancer (2012) Vol. 12, Iss. 12, pp. 860-875
Closed Access | Times Cited: 2539
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini, Justin M. Balko, Ingrid A. Mayer, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 11, pp. 674-690
Open Access | Times Cited: 2381
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman, Laurence Zitvogel, Catheriné Sautès-Fridman, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 717-734
Closed Access | Times Cited: 1882
The tumor microenvironment at a glance
Frances R. Balkwill, Melania Capasso, Thorsten Hagemann
Journal of Cell Science (2012) Vol. 125, Iss. 23, pp. 5591-5596
Open Access | Times Cited: 1666
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay, Elizabeth P. Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S185-S198
Open Access | Times Cited: 1403
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Cancer Cell (2015) Vol. 28, Iss. 6, pp. 690-714
Open Access | Times Cited: 1351
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Yosuke Togashi, Kohei Shitara, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 6, pp. 356-371
Closed Access | Times Cited: 1181
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Carlos Rosales
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 1093
Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
Carsten Denkert, Gϋnter von Minckwitz, Jan C. Brase, et al.
Journal of Clinical Oncology (2014) Vol. 33, Iss. 9, pp. 983-991
Open Access | Times Cited: 959
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
Laura Bracci, Giovanna Schiavoni, Antonella Sistigu, et al.
Cell Death and Differentiation (2013) Vol. 21, Iss. 1, pp. 15-25
Open Access | Times Cited: 838
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel, Lorenzo Galluzzi, Mark J. Smyth, et al.
Immunity (2013) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 786
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
OncoImmunology (2014) Vol. 3, Iss. 9, pp. e955691-e955691
Open Access | Times Cited: 755
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero, Gustav Gaudernack, Winald R. Gerritsen, et al.
Nature Reviews Clinical Oncology (2014) Vol. 11, Iss. 9, pp. 509-524
Open Access | Times Cited: 709
Systems biology of cisplatin resistance: past, present and future
Lorenzo Galluzzi, Ilio Vitale, Judith Michels, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 5, pp. e1257-e1257
Open Access | Times Cited: 704
Breast cancer: Biology, biomarkers, and treatments
Khadijeh Barzaman, Jafar Karami, Zeinab Zarei‐Behjani, et al.
International Immunopharmacology (2020) Vol. 84, pp. 106535-106535
Closed Access | Times Cited: 606
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi, Sandra Pommey, Benjamin Haibe‐Kains, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 27, pp. 11091-11096
Open Access | Times Cited: 456
Molecular mechanisms of ATP secretion during immunogenic cell death
Isabel Martins, Yan Wang, Michael Michaud, et al.
Cell Death and Differentiation (2013) Vol. 21, Iss. 1, pp. 79-91
Open Access | Times Cited: 445
Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 440
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams, James Smothers, Roopa Srinivasan, et al.
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 9, pp. 603-622
Closed Access | Times Cited: 432
Combinatorial Strategies for the Induction of Immunogenic Cell Death
Lucillia Bezu, Ligia C. Gomes-de-Silva, Heleen Dewitte, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 377
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Abhishek D. Garg, Patrizia Agostinis
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 126-148
Open Access | Times Cited: 374
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh, Malika Trad, Neale T. Hanke, et al.
Cancer Research (2013) Vol. 74, Iss. 1, pp. 104-118
Open Access | Times Cited: 371
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apétoh, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 349
Mouse models in oncoimmunology
Laurence Zitvogel, Jonathan M. Pitt, Romain Daillère, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 12, pp. 759-773
Closed Access | Times Cited: 309
Page 1 - Next Page

Scroll to top